R&D expense · 2018–2025
Legend Biotech R&D expense
$415M+0.3% · FY2025
Legend Biotech (LEGN) reported $415M in R&D expense for fiscal 2025, +0.3% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $415M | +0.3% | Open → |
| FY20242024-12-31 | $414M | +8.2% | Open → |
| FY20232023-12-31 | $382M | +13.9% | Open → |
| FY20222022-12-31 | $336M | +7.1% | Open → |
| FY20212021-12-31 | $313M | +35.0% | Open → |
| FY20202020-12-31 | $232M | +43.4% | Open → |
| FY20192019-12-31 | $162M | +167.1% | Open → |
| FY20182018-12-31 | $60.6M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +31.6%
Figures are reported under IFRS, in US dollars.
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Legend Biotech R&D expense |url=https://companiesranked.com/en/company/legend-biotech/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Legend Biotech R&D expense. CompaniesRanked. https://companiesranked.com/en/company/legend-biotech/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-legend-biotech-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Legend Biotech R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/legend-biotech/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001801198-26-000008 · March 10, 2026
{{cite web |title=Legend Biotech R&D expense — 20-F (0001801198-26-000008) |url=https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.